Effectiveness of Giving an HIV Vaccine (Remune) to HIV-Positive Patients Receiving an Anti-HIV Drug Combination

NCT00005758 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

472

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: ALVAC(2)120(B,MN)GNP (vCP1452)
BIOLOGICAL: HIV-1 Immunogen

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)